05:56 20-12-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
18:43 22.5 doctors fall at 10 thousand population in Kyrgyzstan18:27 AsiaUniversalBank's offshore partner appears in Ukraine18:06 Government to allocate up to 5 bln som for agricultural financing project in 201517:46 State-owned companies of Kyrgyzstan work without effect17:35 Kazakhstan, Jordan develop diplomatic ties17:34 Ministries, departments finishing draft of state program on affordable housing until 203017:12 Kenya's President passes controversial security bill16:03 Health Minister submits materials into missing 3 thousand insulin injections to Prosecutor General16:01 Birds 'heard tornadoes coming' to U.S. and fled one day ahead15:33 First Vice PM offers Kyrgyz farmers to take advantage of weakening ruble15:28 Turkey, Kazakhstan to build thermal power plant15:08 Peoples' Assembly of Kyrgyzstan celebrates 20 years15:01 Foreign trade turnover of Tajikistan makes up $4.8 billion in 2014 - authorities14:59 Farmers of Kyrgyzstan receive agricultural machinery14:50 Pakistani military strikes targets in northwest following school massacre, dozens of militants dead14:45 Government increases number of citizens eligible to form a political party 12 times14:44 HRW: Uzbek government should free everyone imprisoned on politically motivated charges under its Constitution Day amnesty14:37 Coalition of human rights: World Bank should investigate whether bank projects contributing to forced labor in Uzbekistan14:20 Tajikistani Amonatbonk signs new loan accord with China Development Bank14:03 Former head of Amanbank's branch detained for 10-mln-som embezzlement
Astana
-9° C
Ashgabat
+13° C
Bishkek
+4° C
Dushanbe
+8° C
Tashkent
+10° C
exchange rates
 
71.02
57.60
9.31
0.97
224.34
182.05
29.30
3.01
6.47
5.24
0.84
0.09
2984.62
2409.67
388.81
45.20
3.50
2.85
0.46
0.05

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75